...
首页> 外文期刊>BJU international >The oncological results of laparoscopic nephroureterectomy for upper urinary tract transitional cell cancer are equal to those of open nephroureterectomy.
【24h】

The oncological results of laparoscopic nephroureterectomy for upper urinary tract transitional cell cancer are equal to those of open nephroureterectomy.

机译:腹腔镜肾结直肠癌切除术治疗上尿路移行细胞癌的结果与开放性肾结石切除术相同。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVE: To compare the overall, tumour-specific, recurrence-free, and progression- free survival of patients with upper urinary tract transitional cell carcinoma (UUT-TCC) treated with laparoscopic nephroureterectomy (LNU) or standard open NU (ONU). PATIENTS AND METHODS: Clinical, pathological and follow-up data were analysed for 43 LNUs and 59 ONUs performed at our institution from 1999 to 2006. In LNU the kidney was removed laparoscopically as in radical nephrectomy, but without transecting the ureter. The specimen was then removed intact with the entire ureter and a bladder cuff through a nonmuscle-splitting supra-inguinal incision. ONU was performed through separate intercostal and supra-inguinal incisions with the entire specimen being removed intact with a bladder cuff through the latter. RESULTS: The mean (SD) follow-up was 41 (20) months for LNU and 41 (29) for ONU. Pathological staging was: pTa 26% vs 20%, pT1 21% vs 27%, pT2 12% vs 17%, pT3 42% vs 34% for LNU and ONU, respectively. In all,seven vs six patients had positive nodes on final histology. Recurrent tumours in the bladder were detected in 26% of patients after LNU and in 27% after ONU after the mean follow-up. There were no local recurrences after LNU but there was local recurrence in six patients after ONU. There were no port-site metastases during the follow-up. Five LNU patients and seven ONU patients developed distant or lymph node metastasis. The actuarial 5-year tumour free-survival rate was 79% in the LNU group vs 76% in the ONU group (P = 0.82). The actuarial disease-specific survival at 5-years was 85% for LNU and 80% for ONU patients (P = 0.62). The surgical approach did not influence recurrence or survival. CONCLUSION: Oncological results of LNU and ONU are comparable. The lower morbidity of LNU offers advantages for the patient.
机译:目的:比较经腹腔镜肾结石切除术(LNU)或标准开放性NU(ONU)治疗的上尿路移行细胞癌(UUT-TCC)患者的总体,肿瘤特异性,无复发和无进展生存期。患者与方法:分析了我们机构自1999年至2006年进行的43例LNU和59例ONU的临床,病理和随访数据。在LNU中,如同根治性肾切除术一样,通过腹腔镜切除肾脏,但未横切输尿管。然后通过非肌肉分裂的上-小便上切口将整个输尿管和膀胱袖口完整地取出标本。 ONU通过分开的肋间和膀胱上膜切口进行,整个标本通过膀胱套囊完整切除。结果:LNU平均随访(SD)为41(20)个月,ONU平均为41(29)。病理分期为:LNU和ONU的pTa分别为26%vs 20%,pT1 21%vs 27%,pT2 12%vs 17%,pT3 42%vs 34%。总共有7例和6例患者的最终组织学淋巴结阳性。平均随访后,在LNU后26%的患者和ONU后27%的患者中发现了膀胱复发性肿瘤。 LNU术后无局部复发,但ONU术后有6例发生局部复发。随访期间无港口现场转移。 5名LNU患者和7名ONU患者发生了远处或淋巴结转移。 LNU组的5年无肿瘤精算生存率为79%,ONU组为76%(P = 0.82)。 LNU的5年精算疾病特异性存活率为85%,ONU患者为80%(P = 0.62)。手术方法不影响复发或生存。结论:LNU和ONU的肿瘤学结果具有可比性。 LNU的较低发病率为患者带来了好处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号